Técualt-Gómez R, Atencio-Chan A, Cario-Méndez AG, Amaya-Zepeda RA, Balderas-Martínez J, González-Valladares JR

Language: Spanish
References: 10
Page: 191-195
PDF size: 595.70 Kb.

ABSTRACT

The bone liposclerosing myxofibrous tumor (LSMFT) was initially described by Ragsdale in 1986 as a polymorphic fibroosseous bone lesion with a mix of histologic elements that include lipoma, fibroxanthoma, myxoma, myxofibroma, fat necrosis, ischemic ossification, areas of fibrous dysplasia, and infrequent presence of cartilage or cystic changes. The most frequently reported location is the intertrochanteric area of the femur. Radiologically it is a lytic, geographic lesion, with well-defined margins and usually sclerotic. In some cases findings include mineralization inside the lesion or a certain degree of expansion to the contour. The close relationship between LSMFT and fibrous dysplasia has been described based on the histologic characteristics and the presence of the Gsα mutation. Another hypothesis of the etiology of the lesion is the reaction of fibrous dysplasia to stress.

REFERENCES

1. O’Dwyer HM, Al-Nakshabandi NA, Saliken J, Munk PL, Nielsen TO, Masri B, et al: Liposclerosing myxofibrous tumour. European Journal of Radiology Extra. 2005; 55: 83-7.

2. Nieto A, Pérez-Andrés R, Lorenzo JC, Vilanova JC: Diagnostic imaging of liposclerosing myxofibrous tumor of bone. Radiologia. 2010; 52(3): 251-4.

3. Corsi A, De Maio F, Ippolito E, Cherman N, Gehron-Robey P, Riminucci M, et al: Monostotic fibrous dysplasia of the proximal femur and liposclerosing myxofibrous tumor: which one is which? J Bone Miner Res. 2006; 21(12): 1955-8.

4. Heim-Hall JM, Williams RP: Liposclerosing myxofibrous tumour: a traumatized variant of fibrous dysplasia? Report of four cases and review of the literature. Histopathology. 2004; 45(4): 369-76.

5. Campbell K, Wodajo F: Case report: two-step malignant transformation of a liposclerosing myxofibrous tumor of bone. Clin Orthop Relat Res. 2008; 466(11): 2873-7.

6. Gilkey FW: Liposclerosing myxofibrous tumor of bone. Hum Pathol. 1993; 24(11): 1264.

7. Ragsdale BD: Polymorphic fibro-osseous lesions of bone: an almost site-specific diagnostic problem of the proximal femur. Hum Pathol. 1993; 24(5): 505-12.

8. Ragsdale BD, Sweet DE, Bone IN, Henson E, Albores-Saavedra J: The pathology of incipient neoplasia. Philadelphia, PA: WB Saunders; 1986: 381-423.

9. Kransdorf MJ, Murphey MD, Sweet DE: Liposclerosing myxofibrous tumor: a radiologic-pathologic-distinct fibro-osseous lesion of bone with a marked predilection for the intertrochanteric region of the femur. Radiology.1999; 212(3): 693-8.

10. Matsuba A, Ogose A, Tokunaga K, Kawashima H, Hotta T, Urakawa S, et al: Activating Gs alpha mutation at the Arg201 codon in liposclerosing myxofibrous tumor. Hum Pathol. 2003; 34(11): 1204-9.